Patients with von Hippel-Lindau (VHL) disease develop tumors in a range of tissues, but existing mouse models of Vhlh mutation have failed to reproduce these lesions. Epididymal cystadenomas arise frequently in VHL patients, but VHL mutation alone is believed to be insufficient for tumor formation, implying a requirement for cooperating mutations in epididymal pathogenesis. Here we show that epididymal cystadenomas from VHL patients frequently also lack expression of the PTEN tumor suppressor and display activation of phosphatidylinositol 3-kinase (PI3K) pathway signaling. Strikingly, while conditional inactivation of either Vhlh or Pten in epithelia of the mouse genital tract fails to produce a tumor phenotype, their combined deletion causes benign genital tract tumors with regions of squamous metaplasia and cystadenoma. The latter are histologically identical to lesions found in VHL patients. Importantly, these lesions are characterized by expansion of basal stem cells, high levels of expression and activity of HIF1alpha and HIF2alpha, and dysregulation of PI3K signaling. Our studies suggest a model for cooperative tumor suppression in which inactivation of PTEN facilitates epididymal cystadenoma genesis initiated by loss of VHL.
Patients with von Hippel-Lindau (VHL) disease develop tumors in a range of tissues, but existing mouse models of Vhlh mutation have failed to reproduce these lesions. Epididymal cystadenomas arise frequently in VHL patients, but VHL mutation alone is believed to be insufficient for tumor formation, implying a requirement for cooperating mutations in epididymal pathogenesis. Here we show that epididymal cystadenomas from VHL patients frequently also lack expression of the PTEN tumor suppressor and display activation of phosphatidylinositol 3-kinase (PI3K) pathway signaling. Strikingly, while conditional inactivation of either Vhlh or Pten in epithelia of the mouse genital tract fails to produce a tumor phenotype, their combined deletion causes benign genital tract tumors with regions of squamous metaplasia and cystadenoma. The latter are histologically identical to lesions found in VHL patients. Importantly, these lesions are characterized by expansion of basal stem cells, high levels of expression and activity of HIF1␣ and HIF2␣, and dysregulation of PI3K signaling. Our studies suggest a model for cooperative tumor suppression in which inactivation of PTEN facilitates epididymal cystadenoma genesis initiated by loss of VHL.
Inheritance of a mutant allele of the von Hippel-Lindau (VHL) tumor suppressor gene results in the VHL familial cancer syndrome, in which patients are predisposed to develop a variety of tumors, including central nervous system and retinal hemangioblastomas, endolymphatic sac tumors, phaeochromocytomas, pancreatic microcystic adenomas, neuroendocrine tumors, clear cell renal cell carcinomas, epididymal cystadenomas in males, and broad ligament cystadenomas (also known as APMO [adnexal papillary cystadenoma of probable mesonephric origin]) in females (15, 21) . The last two tumor types occur in tissues that derive from the embryonic mesonephric duct (also called the Wolffian duct), suggesting that similar genetic events may underlie tumorigenesis in these two tissues.
While epididymal cystadenomas are benign lesions that occur very rarely in the general population, macroscopic lesions arise in approximately 50% of male VHL patients (4) , and it is believed that microscopic lesions may be present in almost all male VHL patients (9) . These lesions are characterized by deletions or mutations of the remaining wild-type VHL allele (7, 9, 38) . Consistent with the known role of pVHL as a component of a ubiquitin ligase complex that targets the hypoxiainducible factor ␣ (HIF␣) transcription factors for normoxic proteolytic degradation (26) , epididymal cystadenomas display accumulation of HIF1␣ and HIF2␣, as well as high levels of expression of the HIF␣-inducible proteins CA9, GLUT-1, and vascular endothelial growth factor (VEGF) (9, 20) . Similar to conclusions drawn from analysis of other tumor-prone tissues in VHL patients (8, 25, 47, 48) , mutational inactivation of VHL alone appears to be insufficient to cause the formation of an epididymal cystadenoma. Rather, while small VHL mutant lesions are detected frequently within the efferent ductules of VHL patients, frank cystadenomas occur relatively rarely (9) . One interpretation of this result is that additional mutations may be required for tumor progression.
The phosphatase and tensin homologue (PTEN) tumor suppressor gene is mutated at high frequency in many different tumor types, and patients that inherit a mutant allele of PTEN (Cowden's disease) are predisposed to develop multiple hamartomatous and mucocutaneous lesions and are at increased risk of developing diverse neoplasms (reviewed in reference 2). Among other functions, PTEN acts as a lipid phosphatase to dephosphorylate phosphatidylinositol 3,4,5-triphosphate that is formed as a result of the activity of phosphatidylinositol 3-kinase (PI3K) enzymes (24) . PTEN thereby opposes signal transduction by numerous cell surface receptors. Inactivation of PTEN results in constitutive activation of multiple signaling cascades that are activated by PI3K, AKT, mTOR, S6K, and c-Jun N-terminal kinases (2, 46) and leads to alteration of transcriptional programs that are controlled by FOXO family and Jun family transcription factors (1, 46) . In general, loss of PTEN function and constitutive signaling via the PI3K signaling pathway result in cellular proliferation.
Here we demonstrate that loss of PTEN expression and activation of PI3K signaling occur frequently in epididymal cystadenomas from human VHL patients. While the individual deletion of Vhlh or Pten in genital epithelia of mice causes a relatively mild phenotype, Vhlh Pten double mutant mice develop tumors that contain regions of clear cell cystadenoma that mimic the epididymal clear cell cystadenomas that develop in human VHL patients. These studies highlight a novel cooperative genetic interaction with respect to tumor suppression by Vhlh and Pten.
MATERIALS AND METHODS
VHL patient epididymal cystadenomas. Two paraffin-embedded epididymal cystadenoma biopsies from VHL patients were previously described (9) ; Pten fl/fl mice by using standard techniques and were infected with high-titer adenovirus expressing Cre recombinase (17) .
Immunohistochemistry and X-Gal staining. Immunohistochemistry was performed as previously described (45) , using the following antibodies: anti-CA9 (M75) (31), anti-involucrin (SY5; Sigma), anti-keratin 6 (PRB-169P; Covance), anti-keratin 14 (PRB-155P; Covance), anti-Notch4 (sc-5594; Santa Cruz Biotechnology), anti-p63 (clone 4A4; Lab Vision), anti-PTEN (9559; Cell Signaling Technology), anti-phospho-Ser240/244 S6 ribosomal protein (2215; Cell Signaling Technology), anti-phospho-Ser65 4E-BP1 (9451; Cell Signaling Technology), anti-von Willebrand factor (F3520; Sigma), and anti-mouse pVHL CT (45) . Immunohistochemistry using anti-HIF1␣ (NB100-105; Novus Biologicals) and anti-HIF2␣ (PM8) (34) antibodies was performed using a Dako Cytomation catalyzed signal amplification system. X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) staining was performed on 50-m-thick cryosections of freshly frozen tissue as previously described (37) .
Western blotting. Whole epididymal protein extracts were prepared by powdering freshly frozen epididymis under liquid nitrogen, followed by homogenization in TNN buffer (25 mM Tris-HCl, pH 7.2, 150 mM sodium chloride, 10% glycerol, 1% NP-40, 10 mM sodium fluoride, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 10 g/ml aprotinin). Thirty to 60 g of boiled protein extract was run in 8 to 15% acrylamide gels, transferred to nitrocellulose membranes, and visualized by immunoblotting with the following antibodies: anti-phospho-Ser473-AKT (4058; Cell Signaling Technology), anti-AKT (sc-1619; Santa Cruz), anti-phospho-Thr202/Tyr204 ERK1/2 (9101; Cell Signaling Technology), anti-phospho-Ser9 GSK3␤ (2215; Cell Signaling Technology), anti-HIF2␣ (PM8) (34), anti-LDH-A (sc-27230; Santa Cruz), anti-PTEN (sc-7974; Santa Cruz), anti-phospho-Ser240/244 S6 ribosomal protein (2215; Cell Signaling Technology), anti-S6 ribosomal protein (2212; Cell Signaling Technology), and anti-mouse pVHL CT antibody (45) . To detect GLUT-1 using anti-GLUT-1 antibody (ab14683; Abcam), protein lysates were not boiled prior to sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Real-time PCR analysis. Total RNA was prepared from powdered tissue by use of an RNeasy minikit (Qiagen), and cDNA was prepared using random hexanucleotide primers and Ready-to-Go You-Prime first-strand beads (GE Healthcare). Genomic DNA was isolated by digesting powdered tissue overnight at 55°C in buffer containing 500 mg/ml proteinase K, 1% sodium dodecyl sulfate, 50 mM EDTA, 150 mM NaCl, and 10 mM Tris-HCl, pH 7.5, followed by phenol-chloroform treatment and precipitation with isopropanol. Real-time PCR analysis of cDNA and genomic DNA was conducted using Absolute Sybr green (Abgene) and the following primer pairs: for TAp63, 5ЈGTGGATGAAC CTTCCGAAAA3Ј and 5ЈGAGGAGCCGTTCTGAATCTG3Ј; for ⌬Np63, 5ЈC AAAACCCTGGAAGCAGAAA3Ј and 5Ј GAGGAGCCGTTCTGAATCTG 3Ј; for Glut-1, 5ЈGCTTATGGGCTTCTCCAAACT3Ј and 5ЈGGTGACACCTC TCCCACATAC3Ј; for Vegf-a, 5ЈCTTGTTCAGAGCGGAGAAAGC3Ј and 5Ј ACATCTGCAAGTACGTTCGTT3Ј; for Delta-1, 5ЈCAGGACCTTCTTTCGC GTATG3Ј and 5ЈAAGGGGAATCGGATGGGGTT3Ј; for Jag-2, 5ЈGCGACC AGTACGGCAACAA3Ј and 5ЈGGGACACACTCGTCACAGAA3Ј; for Hes-1, 5ЈCCAGCCAGTGTCAACACGA3Ј and 5ЈAATGCCGGGAGCTATCTTTCT 3Ј; for Hey-1, 5ЈGTCTCCCATCTCAACAACTACG3Ј and 5ЈGTGTGGGTGA TGTCCGAAGG3Ј; for Hey-2, 5ЈCAATTCACCGACAACTACCTCTC3Ј and 5ЈGCCTTTTCTAACTTGGCAGATCC3Ј; for 18S rRNA, 5ЈTGGCCGACCAT AAACGATGCC3Ј and 5ЈTGGTGGTGCCCTTCCGTCAAT3Ј; for the Vhlh locus, 5ЈACAGTAGGACCACATGAAGATAGG3Ј and 5ЈTCGAGCTTTACC CACCTCTCTAG3Ј; and for the p63 locus, 5ЈGAGGAGCCGTTCTGAATC TG3Ј and 5ЈTAATGCCAATTTTATTGAGC3Ј.
RESULTS
Loss of PTEN expression in epididymal cystadenomas in VHL patients. To investigate pathways that may contribute to the development of human epididymal cystadenoma, we identified 15 microscopic VHL mutant clear cell papillary cystadenomas in epididymal biopsies from three patients with VHL disease. The lesions stained positively for the HIF␣ target gene CA9 (Fig. 1A) (9) . While the tumor suppressor protein PTEN was detected by immunostaining in normal epididymal tubules that lacked expression of CA9 (Fig. 1B) , its expression was reduced or absent in tumor cells of 11 of 15 cystadenomas ( (37) . In addition to expression in the kidney, this transgene directs Cre recombinase expression to the Wolffian and Müllerian ducts of the mesonephros during embryonic development (37) . The Wolffian duct gives rise to the epididymis, vas deferens, and vesicular glands in males, and the Müllerian duct gives rise to the oviducts, uterus, and cervix in females (51) . X-Gal staining of mice carrying the Ksp1.3-Cre transgene and a ROSA26 Cre reporter transgene (ROSA26R) (40) , in which transcription of the lacZ gene occurs only after Cre-mediated excision of a loxP-flanked transcriptional termination sequence, confirmed that the Ksp-1.3 transgene directs Cre activity to the epithelia of genital tissues (Fig. 2) . Western blotting of epididymal tissue demonstrated that Ksp1.3-Cre efficiently reduced the expression of pVHL and PTEN proteins (see Fig. 10L ). These mice displayed a range of striking phenotypes in tissues of the male and female genital tracts.
In Ksp1.3-Cre; Vhlh fl/fl mice (hereafter referred to as Vhlh ⌬/⌬ mice), the male and female genital tracts appeared morphologically and histologically normal ( Fig. 3D and H; 4B, F, and J; and 5D), with the exception of increased vascularization, as shown by the aberrant presence of dilated blood capillaries surrounding epididymal tubules ( Fig. 3H and 4B, arrowheads). Staining using an antibody against the endothelial cell marker von Willebrand factor confirmed that these structures represent blood vessels (Fig. 6B ). This finding is consistent with the known role of VHL inactivation in promoting angiogenesis and with the elevated levels of Vegf-a mRNA in this tissue of Vhlh ⌬/⌬ mice (see Fig. 10K ). Moreover, these findings are also consistent with the results of analysis of human VHL epididymal tissue that argue that loss of VHL alone causes neoangiogenesis but is not sufficient to cause formation of cystadenoma (9) .
Genital tissues of Ksp1.3-Cre; Pten fl/fl mice (hereafter referred to as Pten ⌬/⌬ mice) were enlarged ( Fig. 3E and data not shown). Epithelial hyperplasia was observed in the epididymis ( Fig. 3I and 4C ), vesicular glands ( (Fig. 7C ), which normally is expressed in basal layer keratinocytes that maintain proliferative capacity, and of keratin 6 (K6) (Fig. 7G ), which is expressed by proliferating keratinocytes during wound healing and in culture (6) . These lesions lacked expression of involucrin ( (hereafter referred to as Vhlh ⌬/⌬ Pten ⌬/⌬ mice) double mutant mice developed benign mixed adenosquamous genital tract tumors. In 8-week-old male mice, genital tissues were noticeably enlarged ( Fig. 3F and data not shown), and by 14 weeks of age, the entire genital tract was grossly deformed (Fig. 3B ). Histological analysis of tumors in the epididymis (Fig. 3J and  4D ), vesicular glands (Fig. 4H) , and vas deferens ( by adenoid structures (Fig. 3J ) that were histologically identical to the cystadenoma lesions that arise in the epididymides of VHL patients. Consistent with the role of pVHL in suppressing angiogenesis, epididymal cystadenomas exhibited a highly vascularized stromal component (Fig. 6D) . Epididymal cystadenomas and renal cell carcinomas in VHL patients are characterized by clear cell morphology, which results from the accumulation of lipids and glycogen, which prevent staining by the cytoplasmic dye eosin. Similarly, regions of cystadenoma in Vhlh ⌬/⌬ Pten ⌬/⌬ mice displayed clear cell morphology (Fig.  3K) .
Intermingled with regions of cystadenoma in Vhlh ⌬/⌬ Pten ⌬/⌬ mice were regions of squamous differentiation ( Fig. 3J and L) that recapitulate epidermal differentiation. Evidence for this conclusion includes hematoxylin and eosin staining that revealed the presence of a multilayered epidermis-like structure, blue-staining keratin droplets in terminally differentiated cells (Fig. 3M, arrowheads) , and pink-staining secreted keratin fibers (Fig. 3M, arrows) . Immunohistochemical staining for the expression of the squamous differentiation markers K14, K6, and involucrin ( Fig. 8J and 9D and I) confirmed that lesions in Vhlh ⌬/⌬ Pten ⌬/⌬ mice express markers of proliferating and terminally differentiated keratinocytes. In contrast, regions of cystadenoma did not display markers of squamous differentiation ( Fig. 9E and J) .
Immunohistochemical staining using antibodies against pVHL (Fig. 3O to Q) and PTEN ( Fig. 3R to T) confirmed the deletion of both genes in regions of cystadenoma and squamous metaplasia. In the epididymides of 8-week-old mice, we could identify discrete sites that presumably represent the ear- liest stage of development of these lesions. Regions of cystadenoma and squamous differentiation appear to coarise within otherwise morphologically normal epididymal tubules. Regions that are apparently precursors of cystadenoma occur at the basal surface of the tubule (Fig. 3N , area labeled CA), and layers of cells that are undergoing squamous differentiation overlie these cystadenoma precursors and project toward the center of the epididymal tubule (Fig. 3N, area labeled SM) . Thus, regions of cystadenoma and squamous differentiation appear to arise at the same site. Tumor phenotypes were also observed in the genital tracts of female Vhlh ⌬/⌬ Pten ⌬/⌬ mice (Fig. 5B) , including hyperplasia and full squamous differentiation of the uterine endometrial lumen (Fig. 5F and 7D , H, and L), endometrial hyperplasia (Fig. 5G) , and endometrial hyperplasia with cyst formation (Fig. 5H) . The latter histologically resembles the cystadenoma and cystic lesions seen in the broad ligament in human female VHL patients. Cysts and squamous epithelial hyperplasia also occurred in the cervixes and oviducts of Vhlh ⌬/⌬ Pten ⌬/⌬ mice (data not shown).
Genital tracts of Vhlh ⌬/ϩ Pten ⌬/ϩ mice were indistinguishable from those of wild-type mice. In contrast, the genital tracts of Vhlh ⌬/⌬ Pten ⌬/ϩ and Vhlh ⌬/ϩ Pten ⌬/⌬ mice were initially indistinguishable from those of Vhlh ⌬/⌬ and Pten ⌬/⌬ mice, respectively, but by 6 months of age these mice developed histologically identical lesions to those seen in Vhlh ⌬/⌬ Pten ⌬/⌬ mice (data not shown). However, whereas Vhlh ⌬/⌬ Pten ⌬/⌬ mice developed tumors simultaneously in all genital tract epithelia, tumors arose only at discrete sites in Vhlh ⌬/⌬ Pten ⌬/ϩ and Vhlh ⌬/ϩ Pten ⌬/⌬ mice. Therefore, it is likely that these tumors arose due to somatic mutation of the remaining wild-type Vhlh or Pten allele.
In summary, genital tract lesions seen in Vhlh 
Expansion of basal cells in tumors in
Vhlh ⌬/⌬ Pten ⌬/⌬ mice. Pseudostratified epithelia of the genitourinary tract, including the epididymal tubules, vesicular glands, vas deferens, prostate, and urothelium, are lined by a population of p63-expressing basal cells (13, 36) . While the functions of basal cells are incompletely characterized for most tissues, detailed studies of the prostate have shown that basal cells act as progenitor cells that are necessary for prostatic development (10) . Based on these findings and the findings that p63-expressing basal cells are important for the formation of other epithelia, including the epidermis and salivary, lachrymal, and mammary glands (27, 52) , it is believed that basal cells may function in adult tissues as progenitor or stem cell-like cells that have the capacity to self-renew as well as to differentiate into different lineages and which thereby act to maintain epithelia (reviewed in reference 10). This idea, however, remains to be proven formally.
To gain insight into the molecular changes that cause normal genital tract epithelia to be reprogrammed to form cystadenomas and epidermis-like structures in Vhlh ⌬/⌬ Pten ⌬/⌬ mice, we focused further analysis on the epididymis. Since deletion of Pten within the prostatic epithelium caused expansion of basal cells (49), we analyzed expression of the basal cell markers p63 and K14 (49, 50) presence of capillaries associated with the tubules (Fig. 8G , arrowheads). In Pten ⌬/⌬ mice, basal cells were not restricted to the basal layer of tubules but were present within regions of hyperproliferation ( Fig. 8C and H, arrows) . This finding is consistent with the role of PTEN as a regulator of cell migration (19) . Mislocalization of basal cells may contribute to the altered architecture of epithelia in Pten ⌬/⌬ mice. In contrast to the relatively mild alteration in basal cell number and localization in Vhlh ⌬/⌬ and Pten ⌬/⌬ mice, dramatically increased numbers of cells that stained positively for p63 and K14 were observed throughout regions of cystadenoma ( Fig. 8D and I ) and squamous metaplasia ( Fig. 8E and J) in the epididymides of Vhlh ⌬/⌬ Pten ⌬/⌬ mice. p63 exists as two isoforms, ⌬Np63 and TAp63, that are generated by alternate promoters. ⌬Np63 is the isoform that is expressed in basal cells in genital tract epithelia (13, 36) and has been shown to be necessary for the development of epithelial tissues (42) . Consistent with these findings, real-time PCR analysis demonstrated that ⌬Np63, not TAp63, is the isoform that is expressed by the expanded pool of basal cells in (Fig. 8K) . Real-time quantitative PCR analysis of genomic DNA demonstrated that the increased expression of ⌬Np63 mRNA does not result from amplification of the p63 gene (Fig. 8L) .
Collectively, these findings suggest that an expansion of basal cells may underlie tumor formation in genital epithelia in Vhlh ⌬/⌬ Pten ⌬/⌬ mice. Cystadenomas appear to result from basal cell proliferation without differentiation, whereas regions of squamous metaplasia contain abundant basal cells in basal layers but also cells that express markers of epidermal differentiation in overlying layers of cells. Thus, combined loss of Vhlh and Pten must alter molecular signaling cascades that influence the proliferation and differentiation of basal cells.
Elevated HIF␣ activity in tumors in Vhlh ⌬/⌬ Pten ⌬/⌬ mice. To investigate such potential molecular changes, we first analyzed the status of activation of the HIF␣ pathway. Consistent with the known role of pVHL in degrading HIF␣ transcription factors, immunohistochemical staining revealed strong nuclear accumulation of HIF1␣ in epididymal tubules in Vhlh ⌬/⌬ mice (Fig. 10B ) and in regions of cystadenoma (Fig. 10D ) and squamous metaplasia (Fig. 10E) in Vhlh ⌬/⌬ Pten ⌬/⌬ mice but not in tubules from wild-type or Pten ⌬/⌬ mice ( Fig. 10A and C) . While nuclear staining for HIF2␣ was observed even in wild-type and Pten ⌬/⌬ mice ( Fig. 10F and H) , Vhlh ⌬/⌬ (Fig. 10G) and Vhlh Fig. 10I and J) mice displayed more intense staining. Upregulation of HIF2␣ in epididymal tissues of Vhlh ⌬/⌬ and Vhlh ⌬/⌬ Pten ⌬/⌬ mice was confirmed by Western blotting (Fig.  10L) . Surprisingly, the extent of upregulation of HIF2␣ in Vhlh ⌬/⌬ Pten ⌬/⌬ mice was less than that in Vhlh ⌬/⌬ mice, suggesting that a loss of PTEN activity may alter the balance of expression of HIF␣ family members in response to loss of pVHL. HIF1␣ was not detectable by Western blotting using three commercially available antibodies. Real-time quantitative PCR analysis of the HIF␣-inducible genes Glut-1 and Vegf-a (Fig. 10K) and Western blotting for the HIF␣-inducible proteins GLUT-1 and LDH-A (Fig. 10L) (Fig. 11A) . However, phospho-Ser240/244-S6 ribosomal protein, a downstream marker of mTOR and p70S6K activation, accumulated only in (Fig. 11A) . This effect appears to be specific to S6 ribosomal protein, as Ser9 phosphorylation of glycogen synthase kinase 3␤ (GSK3␤; a site targeted by AKT) and Thr202/Tyr204 phosphorylation of ERK1/2 were not altered by Vhlh and Pten deletion (Fig. 11A) . Immunohistochemical staining confirmed that phospho-Ser240/ 244-S6 ribosomal protein expression is dysregulated in preneoplastic epididymal epithelium of Vhlh ⌬/⌬ Pten ⌬/⌬ (Fig. 11E ) mice but not in Vhlh ⌬/⌬ (Fig. 11C) or Pten ⌬/⌬ (Fig. 11D) mice. Phospho-Ser240/244-S6 ribosomal protein expression is also dysregulated in regions of cystadenoma and is highly upregulated in regions of squamous metaplasia (Fig. 11F) . The mechanism that underlies the cooperative effects of Vhlh and Pten mutation on S6 phosphorylation appears to be tissue specific, as Cre-mediated deletion of Pten alone in mouse embryo fibroblasts (Fig. 11G) or in the kidney (data not shown) was sufficient to induce phosphorylation of AKT and of S6 ribosomal protein in the absence of serum and this was not further modified by combined deletion of Vhlh.
These findings suggest that pVHL normally functions in the epididymis to suppress the activation of downstream components of the PI3K signaling pathway. It is possible that pVHL may therefore limit basal cell proliferation in response to Pten mutation and PI3K and AKT activation. Combined mutation of Vhlh and Pten may allow mTOR and p70S6K activation, which may drive basal cell proliferation.
Elevated Notch signaling in tumors in Vhlh ⌬/⌬ Pten ⌬/⌬ mice. A striking feature of tumors in all genital tract tissues in Vhlh ⌬/⌬ Pten ⌬/⌬ mice is the presence of epidermis-like tissue that arises from the normal simple epithelia that line these tissues. Epidermal differentiation is normally regulated by cross talk between the p63 transcription factor and the Notch signaling pathway that ensures the correct balance between keratinocyte self-renewal and differentiation (29) . Notch downregulates expression of p63 to allow keratinocyte terminal differentiation, and p63 negatively regulates transcription by Notch to inhibit its ability to induce keratinocyte differentiation (29) . Given that combined Vhlh and Pten deletion causes expansion of p63-expressing basal cells and also leads to HIF1␣ activation, it is noteworthy that HIF1␣ has been shown to promote Notch signaling by binding to the cleaved Notch intracellular domain at the promoters of Notch target genes, inducing their expression (11). HIF1␣ has also been shown to induce the expression of the Notch ligand Jag-2 (3). Finally, expression of the active intracellular domains of either Notch1 or Notch4 in transgenic mice induces epididymal hyperplasia (14, 23) .
Given these connections between Notch, HIF␣, hyperproliferation, and squamous differentiation, we investigated the status of Notch signaling pathways in Vhlh ⌬/⌬ Pten ⌬/⌬ mice. Real-time quantitative PCR analysis revealed upregulation of mRNA expression of Notch3 and Notch4, but not Notch1 and Notch2, in epididymides of Vhlh ⌬/⌬ and Vhlh ⌬/⌬ Pten ⌬/⌬ mice (Fig. 12A) . Interestingly, epididymides of Vhlh
mice, but not those of the other genotypes, displayed increased mRNA levels of the Notch ligands Delta-1 and Jag-2 ( Fig. 12B) as well as increased levels of the Notch target genes Hes-1, Hey-1, and Hey-2 (Fig. 12C) . These findings suggest that a (Fig. 12H) . Interestingly, regions of squamous differentiation in Vhlh ⌬/⌬ Pten ⌬/⌬ mice display high levels of p63 in basal layers of cells and transient amplifying keratinocyte-like cells, but p63 expression is absent in terminally differentiated keratinocyte-like cells (Fig. 8E, arrowheads) . In the epidermis, similar downregulation of p63 expression is mediated by Notch (16), supporting the notion that aberrant Notch4 signaling may underlie the squamous differentiation in Vhlh ⌬/⌬ Pten ⌬/⌬ mice.
DISCUSSION
Previous mouse models of Vhlh mutation surprisingly did not develop the characteristic tumors that arise in human VHL patients. However, subsequent careful analysis of VHL patient tissue revealed that kidney, central nervous system, endolymphatic duct, and epididymal tissues all contain many sites of VHL mutation but relatively few frank tumors, suggesting that mutations in addition to VHL mutation may be required for tumor formation (8, 25, 47, 48) . In this study, we present proof of concept of this idea of cooperative tumor suppression in VHL disease. We describe a mouse model of VHL-associated epididymal clear cell cystadenoma that results from combined deletion of the Vhlh and Pten tumor suppressor genes. Consistent with a previous study of VHL patients that demonstrated that loss of pVHL function and HIF␣ activation alone are insufficient to induce the formation of frank epididymal cystadenoma (9), we found that deletion of Vhlh in the epididymis and other genital tract epithelia in mice is sufficient to activate HIF␣ but does not induce epithelial cell proliferation. We show here that epididymal cystadenomas in human VHL patients frequently display loss of PTEN expression, which may contribute to tumor formation in these lesions. (49) . In this respect, we uncovered a cooperative role of Vhlh and Pten mutation in inducing the phosphorylation of ribosomal protein S6, a downstream effector of the PI3K-mTOR-S6K signaling pathway. The presence of Vhlh may thereby limit basal cell expansion in Pten mutant mice. However, Pten deletion in the absence of Vhlh leads to high levels of mTOR and S6K signaling, which may then drive the observed uncontrolled basal cell proliferation. The molecular nature of this genetic cooperation remains unclear and appears to be tissue specific. One possible mechanism that may apply to the epididymis may be that loss of pVHL leads to HIF␣-mediated upregulation of growth factors, such as platelet-derived growth factor and transforming growth factor alpha, that could act in an autocrine or paracrine fashion on Pten-deficient cells to hyperactivate signal transduction through the PI3K-AKT-mTOR-S6K signaling cascade.
Another signaling pathway that may be relevant to tumor formation in the mouse model is the Notch pathway. Tumors of Vhlh ⌬/⌬ Pten ⌬/⌬ mice displayed upregulation of mRNAs encoding the Notch3 and Notch4 receptors and the Notch ligands Delta-1 and Jag-2 and of several Notch-inducible target genes, suggesting that combined Vhlh and Pten deletion leads to aberrant Notch activity in genital epithelia. Since Notch signaling in keratinocytes promotes epidermal differentiation (22, 30, 35) , we reasoned that aberrant Notch activation might contribute to the squamous differentiation phenotype of Vhlh ⌬/⌬ Pten ⌬/⌬ mice. Indeed, we observed specific expression of Notch4 in regions of squamous differentiation. Thus, the epididymides of Vhlh ⌬/⌬ Pten ⌬/⌬ mice reproduce at least two key elements that normally underlie the differentiation of the epidermis: the expanded population of p63-expressing basal cells may function analogously to the p63-expressing basal cells in the epidermis and may be acted upon by aberrant Notch4 signaling, resulting in squamous differentiation.
As discussed by Gläsker et al. (9) , the tissue type of origin of cystadenomas in VHL patients is controversial, with various studies proposing different mesonephric duct-derived tissue, including the epididymal ducts, efferent ductules, vas deferens, testicular appendix, epididymal appendix, and paradidymis. Our findings may reconcile these observations. Since deletion of Vhlh and Pten in the mesonephric duct of mice induces cystadenoma formation in diverse genital tract tissues, it is possible that cystadenomas in VHL patients could form in all of the above-mentioned tissues. Slightly different molecular and cellular events may underlie tumorigenesis at different sites. For example, while tumors derived in mice are characterized by an expansion of basal cells, analysis of three epididymal cystadenomas from human VHL patients did not reveal p63-positive cells (data not shown). This finding is not unexpected, as these particular tumors are likely to have arisen from efferent ductules (9) , an epithelium that is not characterized by the presence of basal cells. It will be interesting in further studies to analyze the activation status of the PI3K signaling pathway and of pathways including p63 and Notch in a larger sample of tumors from different mesonephric ductderived tissues in VHL patients. The awareness that lesions in VHL patients may potentially occur at sites in the genital tract in addition to the epididymis may translate into improved diagnosis for these patients.
In summary, our study provides evidence that additional mutations can cooperate with loss of VHL function in tumorigenesis and suggests that mutations that lead to activation of the PI3K signaling pathway may contribute to the pathology of genital tract tumors associated with VHL deficiency. Since inheritance of VHL mutations predisposes patients to the development of a variety of tumors, including renal cell carcinoma, it is tempting to speculate that mutations that activate the PI3K pathway may contribute to tumor progression more generally in VHL disease. If so, our study suggests that drugs that interfere with the active PI3K signaling pathway may potentially be of therapeutic benefit in genital tract lesions and other cancers that involve VHL mutation.
